Abstract:Opioid addiction is a chronic relapsing disorder in which drug-seeking behavior during abstinence can be provoked by exposure to a µ-opioid receptor (MOR) agonist or opioid-associated cues. Opioid self-administration behavior in laboratory subjects can be reinstated by priming with MOR agonists or agonist-related stimuli, providing a procedure suitable for relapse-related studies. The opioid antagonist naltrexone has been forwarded as a medication that can forestall relapse and, in an extended-release formulation, has demonstrated some treatment success. However, chronic naltrexone treatment has not been extensively investigated in nonhuman subjects and aspects of its pharmacology remain uncertain. For example, the relative effectiveness of naltrexone in reducing the priming strength of opioid agonists differing in efficacy is not well understood. Here, using intravenous self-administration and warm-water tail withdrawal procedures, we investigated changes in the direct reinforcing effects of oxycodone and in the priming strength and antinociceptive effects of opioid agonists in squirrel monkeys (n = 4) during chronic treatment with naltrexone (0.2 mg/kg/d). Results show that naltrexone produced: 1) a 10-fold rightward shift in the dose-response function for the reinforcing effects of oxycodone, and 2) in reinstatement and antinociception experiments, comparable rightward shifts in the dose-response functions for higher-efficacy MOR agonists (methadone, heroin, and oxycodone) but rightward and downward shifts in the dose-response functions for lower-efficacy MOR agonists (buprenorphine, nalbuphine, and butorphanol). These results suggest that, although chronic naltrexone should be effective in forestalling relapse following exposure to lower- and higher-efficacy agonists, the inability of lower-efficacy agonists to surmount naltrexone antagonism may complicate the prescription of opioids for pain. SIGNIFICANCE STATEMENT: Although naltrexone is commonly used in the treatment of opioid use disorder, its ability to reduce the priming strength of opioid agonists has not been extensively investigated. This study shows that chronic naltrexone treatment induces rightward shifts in the reinstatement and antinociceptive properties of higher efficacy opioid agonists, but rightward and downward shifts for lower efficacy opioid agonists, suggesting lower efficacy agonists may not be able to surmount naltrexone-induced antagonism of these two effects, and perhaps naltrexone offers greater protection against lower efficacy agonists.

Effects of Long-Term Sustained Naltrexone Release on the Optic Center in Opioid-Dependent Patients Case-control Study in Four Provinces of China

Effects of Long-term Sustained Release Naltrexone Treatment on Image Recognition in Patients with Opioid Dependence:an ERP Study

Effect of Long-Term Sustained Release Naltrexone on Semantic Recognition of Opioid Addicts

Cue-elicited event-related potential evaluation of long-term sustained release naltrexone treatment for opioid dependence

The ERP Study on the Effective of LSRNTX Treatment for Opioid Dependences on Their Emotion

Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder - a longitudinal structural magnetic resonance imaging study

Effect and Mechanism of Opioid Receptor Antagonist on Allograft Rejection

Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery

The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception

Naltrexone Ameliorates Functional Network Abnormalities in Alcohol‐dependent Individuals

The Impact of Protracted Withdrawal Symptoms on the Compliance of Naltrexone

Investigation of Health Status in Naltrexone Therapy Patients of Heroin Dependent

Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release oxycodone surrounding sequestered naltrexone

AN INVESTIGATION ON EFFICACY OF NALTREXONE THERAPY FOR RELAPSE PREVENTION AFTER DETOXIFICATION IN HEROIN ADDICTS

Naltrexone Differentially Modulates The Neural Correlates Of Motor Impulse Control In Abstinent Alcohol-Dependent And Polysubstance-Dependent Individuals

Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats

Effects of Naltrexone on Large-Scale Network Interactions in Methamphetamine Use Disorder

Naloxone reversed cognitive impairments induced by repeated morphine under heavy perceptual load in the 5-choice serial reaction time task.

Naltrexone and its Effects on Craving and Alcohol Use among Patients with Alcohol Dependence Syndroms: A Report

Specific and nonspecific effects of naltrexone on goal-directed and habitual models of alcohol seeking and drinking

Comparative Analysis of LORETA Z Score Neurofeedback and Cognitive Rehabilitation on Quality of Life and Response Inhibition in Individuals with Opioid Addiction